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Abstract
Ventilator-associated pneumonia (VAP) is the most frequent intensive care unit (ICU)-acquired infection that is
independently associated with mortality. Accurate diagnosis and timely treatment have been shown to improve the
prognosis of VAP. Chest X-ray or computed tomography imaging are used for conventional assessment of VAP, but
these methods are impractical for real-time measurement in critical patients. Therefore, lung ultrasound (LUS) has
been increasingly used for the assessment of VAP in the ICU. Traditionally, LUS has seemed unsuitable for the
detection of lung parenchyma owing to the high acoustic impedance of air; however, the fact that the reflection
and reverberation in the detection region of the ultrasound reflect the underlying pathology of lung diseases has
led to the increased use of ultrasound imaging as a standard of care supported by evidence-based and expert
consensus in the ICU. Considering that any type of pneumonia causes air volume changes in the lungs, accumulating
evidence has shown that LUS effectively measures the presence of VAP as well as dynamic changes in VAP. This review
offers evidence for ultrasound as a noninvasive, easily repeatable, and bedside means to assess VAP; in addition, it
establishes a protocol for qualitative and quantitative monitoring of VAP.
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Background
Mechanical ventilation is an important life-saving thera-
peutic means in the intensive care unit (ICU); however,
its common complication, ventilator-associated pneumo-
nia (VAP), is associated with increased mortality, use of
antimicrobials, mean duration of mechanical ventilation,
and healthcare costs [1, 2]. In developing countries, VAP
occurs in up to 30 % of critically ill patients on mechan-
ical ventilation and the mean rate of VAP varies from 10
to 41.7 cases per 1000 ventilator days [3–6]. In addition,
VAP remains a leading cause of death in hospitalized pa-
tients. The mortality related to VAP varies considerably
in different kinds of patients, with an approximate mor-
tality rate of 16–94 % in developing countries [5]. The
additional financial cost of a VAP episode has been esti-
mated to be more than USD 40,000 [1, 7]. Inappropriate
or delayed treatment of VAP can increase the mortality
rate compared with when adequate therapy is provided
(63.5 versus 29.2 %) [8]. The uncertainties regarding the
most appropriate diagnostic method to identify VAP
compromise the management of this condition [9].
Therefore, early surveillance and accurate diagnosis re-
main the cornerstone to ensure the appropriate use of
antimicrobial agents and to benchmark the rate of VAP.
There is a pressing need to develop reliable monitoring
and diagnostic tools for VAP in order to start treatment
promptly.
Diagnosis of VAP
VAP is defined as a new or progressive and persistent
radiographic abnormality with evidence of infection or
worsening, occurring at least 48 h after the initiation of
mechanical ventilation [10]. Thus far, however, there is
no consensus regarding the diagnostic criteria for VAP.
The current diagnostic criteria for VAP incorporate the
symptoms, inflammation bio-indicators, imaging changes,
and worsening lung aeration function (Table 1) [11–14]. It
is noteworthy, however, that the incidence of VAP varies
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Table 1 Published diagnostic criteria for VAP
VAP criteria Inflammatory marks Sputum Chest radiography/LUS Microbiologic or histopathology marks PEEP/FiO2
CDC criteria [11] Temperature >38 °C, or
>36 °C, or WBC ≥12,000
or ≤4000 cells/mm3 and
new antimicrobial agent




Endotracheal aspirate ≥105 CFU/mL
Broncho-alveolar lavage ≥104 CFU/mL
Protected specimen brush ≥103 CFU/mL
or histological-positive
Lung tissue ≥104 CFU/g or positive for
Legionella, influenza virus, RSV,
adenovirus, or parainfluenza
After a period of stability or
improvement on the ventilator,
Minimum daily FiO2 increase
to 0.20 remain for 2 d or daily
PEEP values increase to 3 cm H2O
CPIS (a score of 6 is
suggestive of VAP) [12]
Temperature 38.5–38.9 °C = 1 point;
≥39 or <36.5 °C = 2 points
WBC <4000 or >11,000/mm3 = 1 point
Non-purulent respiratory
secretions = 1 point;
purulent respiratory
secretions = 2 points
Chest radiography
Diffuse infiltrate = 1 point
Localized infiltrate = 2 points
Progressive infiltrate (without
cardiac disease or ARDS) =
2 points
Moderate or heavy microbiologic
quantitative or heavy microbiologic
quantitative-positive = 1 point
Microbiologic quantitative-positive
and same pathogenic bacteria seen
on Gram stain = 2 points
PaO2/FiO2≤ 240 without
ARDS = 2 points
CEPPIS (a score of 5 is
suggestive of VAP) [12]
Temperature 38.5–38.9 °C = 1 point;
≥39 or <36.5 °C = 2 points
Procalcitonin (ng/mL) ≥0.5 and
<1 = 1 point; ≥1 = 2 points
Non-purulent respiratory
secretions = 1 point;
purulent respiratory
secretions = 2 points
LUS-positive (sub-pleural
echo-poor region or more
with tissue-like echo
texture) = 2 points
Microbiologic culture-positive = 2 points PaO2/FiO2≤ 240 without
ARDS = 2 points
CHEST [13] Temperature >38 °C













ARDS acute respiratory distress syndrome, CDC Centers for Disease Control and Prevention, CEPPIS Chest Echography and Procalcitonin Pulmonary Infection Score, CHEST American College of Chest Physicians, CPIS










widely according to the diagnostic criteria. A previous
study has reported that the incidence of VAP in the same
patient population varied from 4 to 42 % by applying the
different diagnostic criteria listed above [15].
Typically, pneumonia causes air volume changes in
the lungs, which mainly reflect as lung consolidation in
chest X-ray (CXR) or computed tomography (CT) im-
aging. More than 90 % of critically ill patients on mech-
anical ventilation who die in the ICU have histological
evidence of lung parenchymal infection [16]. Hence, the
conventional VAP algorithms emphasize the radiological
findings listed in Table 1. The changes in radiological
findings are intrinsic to most diagnostic VAP algorithms
[17]. However, evidence suggests that the inherent sub-
jectivity and shortcomings of the CXR findings make it
unsuitable for use in the ICU [18, 19]. In response to
this clinical dilemma, the National Healthcare Safety
Network/Centers for Disease Control and Prevention
(CDC) developed a new criterion to improve the object-
ivity and reproducibility of VAP diagnosis in early 2013
[11]. In the newest CDC criteria, radiographic changes
have been replaced by changes in the minimum positive
end expiratory pressure (PEEP) and the fraction of
inspire oxygen (FiO2), which also indirectly reflect air
volume changes in the lungs. The change in minimum
PEEP or FiO2 provides a quantitative and objective
metric for the monitoring and diagnosis of VAP. How-
ever, some clinical studies have found considerable dif-
ferences in surveillance between the novel CDC criteria
and conventional VAP criteria. A prospective cohort
study conducted by Klein Klouwenberg et al. [20] found
that a maximum of 32 % of VAP cases identified by trad-
itional surveillance satisfied the new criteria. The new
criteria show poor concordance with conventional VAP
surveillance, making them a confusing surrogate for the
quality of ICU care. To the best of our knowledge, this
difference in surveillance could be attributed to the
replacement of radiographic abnormalities by changes
in minimum PEEP or FiO2. In addition, a delay in
diagnosis along with the increasingly stringent criteria
could result in an increased mortality rate associated
with VAP from 50 to 80 % [15]. Therefore, a means
or device that enables the direct observation and
quantification of changes in lung volume would pro-
vide a useful and objective metric for the monitoring
and diagnosis of VAP.
Comparison of imaging tools to monitor VAP in the ICU
Currently, international guidelines recommend CXR as a
routine evaluation method for suspected pneumonia in
an adult as it is a simple technique that enables a rapid
diagnosis and provides treatment guidance [21]. How-
ever, CXR has some limitations for the diagnosis of
pneumonia in the ICU. First, CXR findings may be
negative in patients in the early stages of pneumonia or
if the pneumonia is present at a location where it is diffi-
cult to detect. Moreover, CXR cannot sensitively detect
lung consolidations of less than 1 cm [22]. Second, CXR
has a low sensitivity and a relatively low accuracy [23].
Butler et al. [18] evaluated the use of CXR in detecting
VAP in critically ill patients and observed that CXR had
a diagnostic sensitivity of only 25 %, a specificity of
75 %, and an accuracy of 45 % when compared with the
protected specimen brush technique. Other research
also has demonstrated that a normal CXR does not ex-
clude the diagnosis in bedridden patients with suspected
pneumonia [24]. Third, the outcome of radiological find-
ings requires some degree of subjective interpretation.
Fourth, repeated CXR could overexpose some critically
ill patients in the ICU to radiation. These findings sug-
gest that CXR is of limited value for the diagnosis of
pneumonia in patients receiving mechanical ventilation
in the ICU. It is well known that CT imaging is a better
alternative than CXR as it allows visualization of much
smaller pulmonary abnormalities [25]. This chest im-
aging technique offers the highest diagnostic accuracy
for detecting pneumonia [26]. However, it cannot be
routinely used in all patients suspected of pneumonia
owing to its limitations of higher radiation exposure
than CXR, the requirement of more medical assistance,
and the risk involved in transportation to a CT unit [27].
In this context, there is a need for a nonirradiating, non-
invasive, easily repeatable, and bedside method to meas-
ure lung volume changes in the ICU.
Lung ultrasound (LUS) originally seemed to be unsuit-
able for the detection of lung parenchyma because, un-
like X-rays, it is unable to cross the underlying air-filled
anatomical structures to generate a density-related
image. Therefore, LUS was mainly used for the diagnosis
and guided puncture of pleural effusion. With advances
in ultrasound technology and research in recent years,
the advantages of LUS have been gradually realized by
utilizing varying absorption, reflection, and reverberation
patterns of ultrasound for different interfaces of the
lungs. The success of LUS in the diagnosis and monitoring
of community-acquired pneumonia (CAP) has been suc-
cessfully applied to VAP [28]. A multicenter prospective
study demonstrated that LUS is a reliable tool for the
bedside diagnosis of VAP [29]. A Chest Echography and
Procalcitonin Pulmonary Infection Score, a new score
based on LUS results and procalcitonin levels, of >5 points
was significantly better in predicting VAP than a Clinical
Pulmonary Infection Score, based on CXR imaging and
white blood cell count, of >6 points [12]. In addition to its
excellent diagnostic potential, LUS has advantages, such
as high learnability, good diagnostic agreement, and re-
duced radiation exposure. Moreover, it is a simple tech-
nique and requires less sophisticated skills than those
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required for other sonographic scans (e.g., abdominal or
cardiac ultrasound) and the learning curve is faster [30].
In another study conducted by Nazerian et al. [31], LUS
showed a good inter-observer variability (k = 0.83) for the
diagnosis of lung consolidations when compared with CT.
In LUS, the image interpretation itself is less dependent
on the operator, which reduces the degree of subjective in-
terpretation [32]. The use of bedside LUS led to a 26 % re-
duction in CXR and a 47 % reduction in CT scans in the
ICU, which, in turn, reduced the exposure of critically ill
patients to radiation [33]. Therefore, LUS was recom-
mended as a standard of care by evidence-based and ex-
pert consensus to monitor pulmonary infections without
the risk of exposure to radiation and the need for trans-
portation from the ICU [34].
Basic applications of LUS in the ICU
LUS, a recent advance in the ICU, provides direct access
to the majority of the lung surface. To achieve a stan-
dardized and repeatable outcome, some principles in the
application of LUS need to be considered [35]. The first
principle is the gravity rule, which helps to determine
the location of lung lesions. According to this rule, gas
flows toward the sky and fluids flow toward the earth.
Thus, the LUS examination for the pneumothorax
should focus on the anterior parasternal line, while that
for pleural effusion should focus on the posterior axillary
line because air flows to nondependent regions but
pleural effusion flows to dependent regions in a supine
patient. The second principle is the frequency rule,
which helps to choose the appropriate detection fre-
quency for different lesions. According to this rule, the
frequency of sound waves is negatively correlated with
the depth of detection. The high-frequency (5–12 MHz)
wave is most effective in visualizing the chest wall,
pleura, and the lung peripheral parenchyma, while the
3–5-MHz wave mainly helps to visualize the deeper lung
structures. The third principle is the reproducibility rule.
In each examination, standardized thoracic points, such
as the six spots of electrocardiography, should be de-
fined initially to ensure reproducible analyses.
It is well known that the lung is made up of air-filled
pulmonary alveoli, spaced with interlobular septa and
water. The lung aeration and air/liquid ratio beyond the
parietal pleura influence the reflection and reverberation
of ultrasound waves, further determining the LUS im-
ages of the imaged area. Therefore, the real-time LUS
image can indicate the underlying pathology of lung dis-
eases [36]. For quick mastery of LUS in clinical practice,
LUS images are summarized to characteristic sono-
graphic patterns according to the lung pathology
(Fig. 1).
Typically, the surfaces of the visceral and parietal
pleurae slide forward and backward against each other
during respiration. Ultrasound waves are reflected by the
interface of the pleurae, which generate a hyperechoic,
sliding line termed the pleural line with lung sliding
(Fig. 1a). In addition, using the time-motion mode of
ultrasound, lung sliding below the pleural line appears
as a homogenous granular pattern called a sandy sign
(Fig. 1a). On the far side of the pleural line, the lungs
generate linear images called A lines, which are parallel
to the pleural line because of the high acoustic imped-
ance of air, wave reflection, and reverberation. The white
and hyperechoic A lines, which become less intense with
depth, are static and appear at regular intervals (Fig. 1a).
The combination of a pleural line, bilateral lung sliding,
and an A line indicate normal lung aeration (Fig. 1a;
Additional file 1: Video S1). It is noteworthy, however,
that a normal lung pattern can be observed in those with
emphysema or asthma. The B line is a long, vertical,
hyperechoic, and dynamic line that originates from the
pleural line, moves with lung sliding, and spreads to the
edge of the screen without fading the A lines (Fig. 1b;
Additional file 2: Video S2). B lines represent a reverber-
ation artifact through thickened subpleural interlobular
septa by deposition of fibrous tissues, inflammatory cells,
or pulmonary edema [37]. Thus, a B line can be detected
in cardiogenic pulmonary edema, acute respiratory dis-
tress syndrome (ARDS), interstitial lung diseases, pneu-
monia, etc. [37, 38]. The presence of multiple vertical B
lines more than 7 mm apart (spaced B lines) indicates a
moderate decrease in lung aeration due to thickened
interlobular septa. The presence of coalescent B lines
less than 3 mm apart (alveolar interstitial syndromes) in-
dicates a more severe decrease in lung aeration due to
partial filling of alveolar spaces [28]. It should be noted
that detection of fewer than three isolated B lines in
dependent regions of a normal lung could have no
pathological significance [39]. Lung consolidations are
characterized by a tissue-like echotexture similar to
that observed in liver parenchyma on LUS (Fig. 1c;
Additional file 3: Video S3). They are detected in
pneumonia, lung atelectasis, lung contusion, ARDS,
etc. The presence of lung consolidation indicates
complete loss of lung aeration because the alveolar
space is filled with exudates and cellular debris or is
collapsed by the proliferation of neoplastic tissue or
pleural effusion [40]. Within the consolidation, a branch-
shaped or horizontal bronchogram containing air or fluid
can be observed (Fig. 1c). In such cases, an inspiratory
reinforcement corresponding to penetration of air into the
bronchial tree, called a dynamic air bronchogram, can be
occasionally observed [41]. The pneumothorax is charac-
terized by the “lung point”, disappearance of lung sliding,
and the “barcode sign” in the time-motion mode on LUS
(Fig. 2b). The lung point is a characteristic marker of the
pneumothorax (Fig. 1d) [42]. It is the transition between
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normal lung sliding and the absence of lung sliding at the
pneumothorax border. By using the time-motion mode of
ultrasound, the absence of lung sliding appears as strictly
horizontal lines, called the barcode sign (Fig. 1d) [43]. The
absence of lung sliding or B lines is helpful to exclude the
pneumothorax with a 100 % negative predictive value
because these two signs indicate the movement of in-
tact visceral pleura against parietal pleura [43]. Lung
effusion appears as an echo-free zone on LUS, which
helps to differentiate the presence of fluids or consoli-
dation, leading to the opacity of the hemithorax in
ICU patients (Fig. 1e; Additional file 4: Video S4). It
is noteworthy that lung effusion is usually accompan-
ied by another condition such as pneumonia or pul-
monary edema. Thus, understanding the etiology of
pleural effusion through LUS is important.
Applications of LUS in CAP and VAP
LUS has the advantages of good diagnostic efficiency
and real-time monitoring for CAP and VAP. In a study
of 179 patients that compared the accuracy of LUS and
CXR for the diagnosis of CAP, LUS was found to be bet-
ter than CXR (sensitivity of 94.6 versus 77.7 % and ac-
curacy of 96.1 versus 83.8 %, respectively; p < 0.001) [44].
In addition, Bourcier et al. [45] compared the duration
of symptoms with the respective performance of LUS
and CXR for the diagnosis of CAP and observed that
LUS detected more cases of CAP compared with CXR in
the first 24 h of care (76 versus 23 %). This result further
suggested that LUS was more sensitive than CXR in the
early diagnosis of CAP [45]. During the follow-up of pa-
tients with CAP, LUS could effectively monitor the
changes in the lesion area. In a multicenter study to
Fig. 1 Basic characteristic sonographic patterns. The basic characteristic sonographic patterns are illustrated (left) and described according to
distinctive features (right). a A lines are characteristic lines parallel to the pleural line. b B lines are long, vertical, hyperechoic, and dynamic lines
originating from the pleural line, moving with lung sliding. c Lung consolidation is a tissue-like echotexture of the lung with or without a
bronchogram. d The lung point is a point of contact between normal lung sliding (sandy sign) and the absence of lung sliding (barcode sign).
e Pleural effusion is an echo-free zone (P tissue-like echotexture of the lung, E pleural effusion)
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define the accuracy of LUS, the median area of pneu-
monic lesions in patients decreased from 15.3 to 0.2 cm2
on days 13 to 15 compared with the baseline. This
change was in line with the change in the median C-
reactive protein levels of patients along with their im-
proved condition [46]. For VAP, the sensitivity and speci-
ficity of LUS in detecting lung consolidation were 90
and 98 %, respectively, with CT as a gold standard [41].
Because the nature of CAP or VAP is pneumonia in-
duced by pathogens such as bacteria or viruses, the two
types of pneumonia possess similar pathological features,
resulting in homogeneous ultrasound features. The core
feature of VAP or CAP observed on LUS is lung consoli-
dation accompanied by an air bronchogram [41, 46].
However, LUS is more convenient for the diagnosis of
CAP than VAP because patients with CAP are more co-
operative and seldom have thoracic dressings or drainage
tubes.
Diagnosis and management of VAP
Mechanically ventilated patients often show a wide
range of abnormal patterns on LUS. The sonographic
features of VAP can be easily confused with those of
lung cancer, pulmonary embolism, atelectasis, etc., lead-
ing to a 17–26 % rate of misdiagnosis in the critical care
setting [47]. Thus, it is important to establish a protocol
for the accurate diagnosis and monitoring of VAP. This
protocol is required for qualitative and quantitative
examination of the lung with panoramic and dynamic
views, including an understanding of the anatomy,
pathophysiology, and clinical signs of VAP (Fig. 2).
First, panoramic evaluation is achieved by the identifica-
tion of landmarks, longitudinal scans, focal examination,
and overall lung integration [36]. The following landmarks
should be identified: the anterior parasternal line, anterior
axillary line, and posterior axillary line, which divide each
hemithorax into anterior, lateral, and posterior areas, re-
spectively [41, 48]. The anterior and lateral lung regions of
the patients in the ICU are usually evaluated in a supine
position and the posterior region is evaluated in the lateral
decubitus position. Every region of the hemithorax has its
own significance of detection on LUS. Pneumothorax or
interstitial syndrome can be detected in the anterior chest
wall, while for the diagnosis of VAP, LUS of the lateral and
posterior areas, rather than the anterior wall, is performed
[41]. The longitudinal scans are performed from the clav-
icle to diaphragm (mammillary line or one or two inter-
costal spaces below), along the intercostal spaces. The
longitudinal scanning data provide a preliminary view of
the sonographic patterns. A focal examination scans the
area of interest for the accurate identification of the lesion
with different scans (longitudinal, transverse, and oblique
views) and, sometimes, also with different probes. Subse-
quently, all data from the longitudinal scans and focal
examination are translated into a possible clinical decision
and monitoring plan by overall lung integration.
Second, a dynamic and continuous progression from
normal aeration to complete loss of aeration exists in
VAP. When lung aeration is disturbed because of VAP, a
normal LUS pattern gradually changes from the appear-
ance of focal areas of interstitial syndrome (spaced B
lines, which become confluent B lines) to subpleural
Fig. 2 Sequential interpretation of the LUS protocol for detecting VAP. This is a schematic, simplified decision tree of the VAP protocol. The basic
steps include the identification of landmarks, longitudinal scans, focal examination, and overall lung integration. The identification of landmarks is
helpful for standardized and reproducible analyses. The longitudinal scans mainly provide a preliminary view of the sonographic patterns. The
focal examination mainly reveals the characteristic features of a lesion. The overall lung integration enables the translation of all data into a
possible clinical decision and monitoring plan. AIS alveolar interstitial syndromes, VAP ventilator-associated pneumonia
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small consolidations. These subpleural consolidations
can further develop into lobar consolidations [49]. Thus,
the sonographic features of VAP vary according to the
development of the lesion and are determined according
to the distribution characteristics, interstitial changes,
and parenchymal changes [41]. The interstitial changes
of VAP comprise multiple irregularly spaced B lines,
multiple abutting ultrasound lung comets arising from
the plural lines, and a small subpleural consolidation
[28]. The parenchymal characteristic of VAP is lung
consolidation of an inhomogeneous echotexture with
blurred margins and air bronchograms [28, 50, 51].
Among these characteristics, air bronchograms are an
effective marker for the diagnosis of VAP, with a sensi-
tivity of 100 % and a specificity of 60 % [50]. However,
there is a need to differentiate the nature of lung consol-
idations during focal examination because the lesion
may be pneumonia, lung atelectasis caused by mechan-
ical obstruction or compression, tumor consolidation,
pulmonary embolism, etc. For example, lung atelectasis
is characterized by regular margins and no dynamic air
bronchograms. The feature of pulmonary embolism is a
wedge-shaped, hypoechoic consolidation, typically in the
dorsal and basal regions of the lung. However, these fea-
tures of B-mode ultrasound are not sufficiently specific
for the differential diagnosis of VAP. The vascular pat-
tern within the consolidation, as assessed by color
Doppler ultrasound, provides an alternative means for
determining the etiology of pulmonary consolidations
(Table 2) [52, 53]. The vascular pattern indicators, in-
cluding the pulsatility index, the resistance index, and
the duration between the initial and peak systolic vel-
ocity, have been reported to be useful for differentiating
between the consolidations of different etiologies [52].
These results imply that blood flow of lung atelectasis
caused by mechanical obstruction is a high-impedance
flow, pneumonia is a moderate-impedance flow, tumor
consolidation is a low-impedance flow, and pulmonary
embolism is without any blood flow. The discrepancy in
hemodynamic changes observed in the regional pulmon-
ary artery in lung consolidation may be mainly attributed
to reactive vasoconstriction due to local hypoxia [54]. An
air bronchogram is a specific sign for the diagnosis of
VAP, which implies that the resulting reactive vasocon-
striction to hypoxia is less, because air can still enter the
partially filled alveoli during inspiration. In lung atelectasis
caused by mechanical obstruction, the complete airway
obstruction accounts for regional hypoxia and severe re-
active vasoconstriction. Neovascularization is a character-
istic feature of tumor consolidation, which accounts for
the low-impedance flow. However, other researchers also
have found that pulmonary blood flow persists within the
consolidations caused by ARDS or a diffuse alveolar
hemorrhage [55, 56]. These results indicate that the
hemodynamic changes observed in the regional pul-
monary artery during lung consolidation are complex.
However, this phenomenon was consistent with the
increased pulmonary blood flow observed in the dam-
aged regions of an ARDS rat model induced directly
by acid aspiration because the relaxing factors re-
leased from the damaged alveoli limit hypoxic pul-
monary vasoconstriction [57–59].
Third, LUS has been successfully applied for the early
diagnosis of VAP. In a multicenter prospective study that
included 99 patients suspected of VAP, the combined
LUS features of subpleural consolidation and air bronch-
ograms showed a positive predictive value of 86 %
(ClinicalTrials.gov NCT02244723) [29]. However, the
clinical diagnosis of VAP should not be based on the
LUS image alone but on the combination of LUS find-
ings, clinical parameters, and microbiological results.
This combination approach increases the diagnostic ac-
curacy of LUS [29].
Lastly, LUS scoring systems based on the A line, B
line, and lung consolidation have been applied for the
quantitative monitoring of lung aeration and aeration
changes [28, 55, 60, 61]. All these scoring systems divide
lung aeration into four ultrasound patterns for the as-
sessment of aeration and re-aeration observed on LUS.
The four ultrasound patterns include normal aeration
(N; the presence of lung sliding with A lines or fewer
than two isolated B lines), moderate (B1; multiple
Table 2 Spectral waveform analysis of pulmonary arterial flow patterns in different etiologies




Presence of flow signal Detected Detected Detected None detected
Flow signal density High Low Low None
PI ([Peak systolic velocity − End diastolic velocity]/Mean velocity) Median High Low None
RI ([Peak systolic velocity − End diastolic velocity]/Peak systolic velocity) Median High Low None
AT (duration from the beginning to the peak systolic velocity) Median Low High None
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well-defined B lines), severe (B2; multiple coalescent
B lines), and complete (C; the presence of a tissue
pattern characterized by dynamic air bronchograms).
The differences among these scoring systems mainly
lie in the magnitude and changes of ultrasound pat-
terns (Table 3). The accuracy of LUS in assessing
lung aeration in VAP has been demonstrated by con-
structing an LUS-based scoring system [28]. A tight
correlation was observed between the change in the
LUS-based scoring system and CT measurements of
lung aeration after antimicrobial therapy (day 0 versus
day 7). An ultrasound score >5 demonstrated a CT re-
aeration >400 mL and successful antimicrobial therapy.
Thus, LUS is an effective tool to turn images into numbers
(semi-quantification) for evaluating the status of VAP and
the effect of therapy.
Limitations of LUS in VAP
Despite the ease of use, bedside availability, noninvasive-
ness, and repeatability of LUS, this technique may not
be suitable for obese patients with a thick chest wall,
patients with pleural calcifications, noncooperative pa-
tients, and patients with thoracic dressings or a drainage
tube. In addition, about 20 % of the lung surface is not
visualized by LUS owing to the shielding of anatomic
structures (clavicle and scapula) [48]. The detection effi-
ciency of LUS for VAP is also influenced by the lesion
size and by the distance between the lesion and lung
surface. Small consolidations measuring less than
20 mm that are located posteriorly and away from the
pleura may not be detected by LUS [41]. In addition,
there is a need for adequate training among clinicians
who are unfamiliar with the use and interpretation of
ultrasound images. Furthermore, LUS cannot be consid-
ered disease specific. It should always be combined with
the patient history, physical examination, and laboratory
analysis.
Conclusions
Published data show that LUS is an accurate bedside
tool to detect and monitor VAP, especially in the critical
care setting. It helps to reduce the overexposure of
patients to radiation. Therefore, the use of LUS as a
standard of care should be encouraged, especially in the
ICU. However, the presence of specific sonographic fea-
tures merely indicates VAP. Further research regarding a
protocol including LUS findings as well as infectious and
microbiological data is warranted to increase the diag-
nostic efficiency of VAP in clinical practice.
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